Fas-mediated apoptosis in Jurkat cells is suppressed in the pre-G2/M phase

N Hiroi1, H Maruta, S Tanuma

  • 1Department of Biochemistry, Faculty of Pharmaceutical Sciences, Science University of Tokyo, Shinjuku-ku, Tokyo 162, Japan.

Insights

Jurkat cells resistant to Fas-mediated apoptosis during the G2/M phase. This resistance is regulated downstream of Fas signaling, not by Fas expression levels.

Area of Science:

  • Cell Biology
  • Immunology
  • Apoptosis Research

Background:

  • The cell cycle regulates cellular processes, including susceptibility to apoptosis.
  • Fas-mediated apoptosis is a critical pathway for immune regulation and homeostasis.

Purpose of the Study:

  • To investigate the relationship between the cell cycle phases and sensitivity to Fas-mediated apoptosis.
  • To identify the mechanisms underlying differential apoptosis susceptibility during the cell cycle.

Main Methods:

  • Jurkat cells were synchronized using the thymidine double-block method.
  • Apoptosis was induced using an anti-Fas antibody.
  • Fas expression levels were analyzed via cell surface detection.

Main Results:

  • Cells in the G2/M phase exhibited reduced susceptibility to Fas-mediated apoptosis compared to other phases.
  • A significant suppression of apoptosis was observed in the pre-G2/M phase.
  • Fas expression levels remained constant across the cell cycle, indicating regulation occurs downstream of Fas.

Conclusions:

  • G2/M phase Jurkat cells are inherently more resistant to Fas-mediated apoptosis.
  • The suppression of apoptosis in the pre-G2/M phase is regulated at a post-Fas receptor level.
  • This suggests a cell cycle-dependent mechanism controlling the apoptotic pathway downstream of Fas engagement.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...